AI-guided patient stratification boosts Alzheimer’s trial outcomes and efficiency Post author:admin Post published:July 17, 2025 Post category:uncategorized Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. You Might Also Like RUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancer February 6, 2025 Legalization of cannabis associated with rising use among adolescents October 28, 2024 Using AI to improve gastroscopy diagnostics June 24, 2024